|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | |
| A61K 47/32 | |||
| A61K 9/51 | |||
| A61P 15/00 |
| (11) | Number of the document | 2844227 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13723350.8 |
| Date of filing the European patent application | 2013-05-03 | |
| (97) | Date of publication of the European application | 2015-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/039499 |
| Date | 2013-05-03 |
| (87) | Number | WO 2013/166408 |
| Date | 2013-11-07 |
| (30) | Number | Date | Country code |
| 201261642261 P | 2012-05-03 | US |
| (72) |
POPOV, Alexey, US
|
| (73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
| (54) | PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT |
| PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT |